HomeAboutScientific TeamCode of Good PracticeResearchCOVID-19 TestingCardiac HealthClinical Trial Design & MethodologyHepatologyEthnic and Sex Differences Physiology & Drug ResponsesPublicationsNewsCareersSupportContact

What’s a Rich Text element? (H1)

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

What’s a Rich Text element? (H2)

The rich text element allows you to create and format headings, paragraphs, blockquotes, images, and video all in one place instead of having to add and format them individually. Just double-click and easily create content.

Static and dynamic content editing (H3)

A rich text element can be used with static or dynamic content. For static content, just drop it into any page and begin editing. For dynamic content, add a rich text field to any collection and then connect a rich text element to that field in the settings panel. Voila!

How to customize formatting for each rich text (H4)

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

How to customize formatting for each rich text (H5)

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

How to customize formatting for each rich text (H6)

Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

  • Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.
  • Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.
  • Headings, paragraphs, blockquotes, figures, images, and figure captions can all be styled after a class is added to the rich text element using the "When inside of" nested selector system.

Dr Dominic Pimenta wins the 'Young Investigators Award for Primary Care and Risk Factor Management'

12th April 2022

We are delighted to confirm that RRI's Lead Specialty Research Physician, Dominic Pimenta, has won the Young Investigators Award at the ESC Preventive Cardiology 2022. The online event held earlier this month, 7-9 April, focused on "Implementing Innovation" in preventive cardiology.


Dr Pimenta achieved the award success for his presentation on "Cardiovascular risk factor insights into the Tesco 1.0 Dataset". The Tesco 1.0 Dataset is an open-source insight into the shopping behaviour of 16m Clubcard users in London, organised by borough of residence. We utilised this to explore whether such data correlated with population level cardiovascular outcomes, including ischaemic heart disease, stroke and covid 19 mortality. We demonstrated significant correlations with biologically plausible risk factors and protective factors, including salt and fat, and fibre. We also interesting observed an unexpected protective relationship with ready meal use and covid 19 mortality. We hope to explore this data more in the future to develop a better precision medicine approach to the dietary aspect of health and disease.

Learn more about ESC Preventive Cardiology 2022 and the award winners by visiting their website.

Related News

Characterisation of the Cardiovascular Effects of a Meal: QTcF Assessment and Further Insights into the Physiological Effects

Authored by Georg Ferber, PhD, Dilshat Djumanov, PhD, Ulrike Lorch, MD, FFPM, Edward Jackson, BSc, MSc, PhD, MBChB, Joao Almeida Melo, James Rickard, MPharm, and Jorg Taubel, MD, FFPM, FESC.

RRI study finds antimalaria drug has no negative impact on cardiac safety in healthy volunteers

We studied the cardiac safety of P218 using advanced QTc assessments and found doses of up to 1000mg do not prolong the QTc suggesting a low risk of drug induced arrhythmia.

Phase I study confirms cardiac safety of potential alopecia treatment

Here we present the results of our recent work on the cardiac safety of cortexolone 17α-propionate (cortexolone).

Effectiveness of 12-lead ECG versus Holter monitor confirmed in important trial methodology

12-lead resting ECGs are considered essential in clinical trials, but their limitations have led to increasing use of 12-lead Holter monitor devices.

Cardiac safety of nolasiban confirmed in Phase I clinical trial

Here we report our recent work on the cardiac safety of nolasiban.

Why more caution is needed in administering QT prolonging drugs to type 1 diabetic patients.

Findings from our recent study show how cardiac ion channel blocking agents could increase the risk of sudden cardiac death in patients with type 1 diabetes, particularly in women.

Back to News